Paper Details

  1. Home
  2. Paper Details

Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis.

Author: ShaikhW A

Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.

Overview

Budesonide, an inhaled corticosteroid, is used for bronchial asthma and rhinitis. This study investigated whether exhaling budesonide through the nose after inhalation could reduce the dose requirement of budesonide nasal spray in patients with perennial allergic asthma and rhinitis. Results showed that exhaling through the nose significantly improved symptoms and peak nasal inspiratory flow rates, leading to a 40.1% reduction in the dose requirement of budesonide nasal spray.
Paper Details　
Original Abstract of the Article :
Budesonide, an inhaled corticosteroid is used routinely in the treatment of bronchial asthma and rhinitis. Although inhaled corticosteroids in therapeutic doses are unlikely to result in systemic side effects, there is as yet skepticism about their routine and prolonged use. The aim of this study wa...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10212857

データ提供：米国国立医学図書館（NLM）

Budesonide Inhalation: A Double-Duty Solution for Asthma and Rhinitis

The management of [asthma and rhinitis], two common respiratory conditions, often involves the use of [budesonide], an inhaled corticosteroid. This study explores a novel approach to administering budesonide, exploring its potential to reduce the need for nasal sprays in patients suffering from both asthma and rhinitis.

Budesonide Inhalation: A Versatile Approach to Respiratory Health

The study found that inhaling budesonide and exhaling through the nose significantly reduced the need for nasal spray in patients with both asthma and rhinitis. This finding is like discovering a hidden oasis in the vast desert of respiratory treatments, offering a more efficient and potentially convenient approach. The study highlights the potential of this approach for simplifying treatment regimens and improving patient outcomes.

Maximizing the Benefits of Budesonide Inhalation

This study offers valuable insights into the potential of budesonide inhalation as a multifaceted approach to managing asthma and rhinitis. Remember, every patient's experience is unique, and consulting with a healthcare professional is crucial for determining the most appropriate treatment plan for your individual needs.

Dr.Camel's Conclusion

This research suggests that inhaling budesonide and exhaling through the nose could provide a more efficient and convenient approach to managing asthma and rhinitis. It's important to discuss this approach with a healthcare professional to determine if it's the right option for you.

Date :
  1. Date Completed 1999-05-06
  2. Date Revised 2013-07-31
Further Info :

Pubmed ID

10212857

DOI: Digital Object Identifier

10212857

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.